Sanofi India Limited has informed the Exchange that Board of Directors at its meeting held on October 29, 2025, declared Interim Dividend of Rs. 75 per equity share.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India Limited's Board of Directors, at a meeting held on October 29, 2025, approved an interim dividend of Rs. 75 per equity share. This is a straightforward dividend declaration with no accompanying corporate actions like buybacks, splits, or bonus issues mentioned. Sanofi India is a leading pharmaceutical company and a subsidiary of the global Sanofi group. The dividend payout reflects the company's strong cash generation and its practice of returning surplus funds to shareholders.
Positive for shareholders in the short term as it provides a direct cash return. The stock may see mild support near the ex-dividend date, though the broader price reaction depends on the dividend yield relative to the prevailing share price.